New hypolipidemic drugs from the group of reductase inhibitors GMG-CoA

Ítems similars

• Virgin Coconut Oil-based Nanostructured Lipid Carrier Improves the Hypolipidemic Effect of Rosuvastatin
  per: Shehata TM, et al.
  Publicat: (2024-08-01)
• Comparative effects of pravastatin and rosuvastatin on carbohydrate metabolism in an experimental diabetic rat model
  per: Kaya Hacer Kayhan, et al.
  Publicat: (2024-03-01)
• Formulation and Evaluation of Pravastatin Sodium-Loaded PLGA Nanoparticles: In vitro–in vivo Studies Assessment
  per: Elsayed SI, et al.
  Publicat: (2023-02-01)
• Pravastatin inhibits cell proliferation and increased MAT1A expression in hepatocarcinoma cells and in vivo models
  per: Hijona Elizabeth, et al.
  Publicat: (2012-02-01)
• ROLE OF POWERFUL STATINS IN MODERN TREATMENT OF PATIENTS WITH A HIGH RISK OF COMPLICATIONS ARISING FROM ATHEROSCLEROSIS
  per: S. R. Gilyarevskijy, et al.
  Publicat: (2017-11-01)